FKBP5 and schizophrenia: The study by Mitjans et al. investigated the effect of the FKBP5 gene polymorphisms on treatment outcome in patients with schizophrenia showing that TT homozygotes for the rs13860780 polymorphism have higher risk of non-response to clozapine than the C allele carries [64].